TS03 Inc Trust Units TSTIF

RE:RE:RE:RE:Bahahahaha!

[Blue_Sky]

Dr. Wong, If the product is as 'revolutionary' as you suggest then why did Getinge sell less than 10 units in Q1? Why has TSO3 sold next to nothing in its backdoor Canadian market where the product has been approved and has held all claims for many years? Why were consumable revenues lower in Q1 Q/Q suggesting either less units in the field or lower cycles/day? If it is so 'revolutionary' take-up of this product would have ramped even slightly better than this no? How can this failed execution and sales progress not be the fault of the management team? Is that not why we pay RR the bloated salary that he has been taking for years? All the option grants that are eventually exercised and sold? Who should be held accountable for virtually no share gains for the VP4? Certainly not Fidelity or Ninepoint or even Mr. Jones with 1,000 shares? As a professional healthcare investor for +20 years you must be familiar with the hundreds of publicly traded North American med-tech companies that exist. Certainly there are dozens of professionals that are as qualified or more to run this company! I think its time for a change in leadership. RR has been give 10-years to lead this company. Had I told you 3 years ago that we would have anywhere between 50 - 70 units in the field given all of the FDA acknowledgements plus two failed distribution agreements plus fear of a massively dilutive financing and a stock price at 70c would you have believed me?